Hepatic protein Carbonylation profiles induced by lipid accumulation and oxidative stress for investigating cellular response to non-alcoholic fatty liver disease in vitro

被引:12
作者
Chienwichai, Peerut [1 ,2 ]
Reamtong, Onrapak [2 ]
Boonyuen, Usa [2 ]
Pisitkun, Trairak [4 ]
Somparn, Poorichaya [4 ]
Tharnpoophasiam, Prapin [5 ]
Worakhunpiset, Suwalee [5 ]
Topanurak, Supachai [2 ,3 ]
机构
[1] Chulabhorn Royal Acad, Fac Med & Publ Hlth, HRH Princess Chulabhorn Coll Med Sci, Bangkok 10210, Thailand
[2] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok 10400, Thailand
[3] Mahidol Univ, Fac Trop Med, Ctr Excellence Antibody Res, Bangkok 10400, Thailand
[4] Chulalongkorn Univ, Ctr Excellence Syst Biol, Fac Med, Bangkok 10330, Thailand
[5] Mahidol Univ, Fac Trop Med, Dept Social & Environm Med, Bangkok 10400, Thailand
关键词
Non-alcoholic fatty liver diseases; Non-alcoholic steatohepatitis; Fatty acids; Oxidative stress; Redox proteomics; Protein carbonylation; Proteomics; ENERGY-METABOLISM; EXPRESSION; DYSFUNCTION; MECHANISMS; SURVIVAL; DAMAGE; MODEL;
D O I
10.1186/s12953-019-0149-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundNon-alcoholic fatty liver disease (NAFLD) is caused by excessive accumulation of fat within the liver, leading to further severe conditions such as non-alcoholic steatohepatitis (NASH). Progression of healthy liver to steatosis and NASH is not yet fully understood in terms of process and response. Hepatic oxidative stress is believed to be one of the factors driving steatosis to NASH. Oxidative protein modification is the major cause of protein functional impairment in which alteration of key hepatic enzymes is likely to be a crucial factor for NAFLD biology. In the present study, we aimed to discover carbonylated protein profiles involving in NAFLD biology in vitro.MethodsHepatocyte cell line was used to induce steatosis with fatty acids (FA) in the presence and absence of menadione (oxidative stress inducer). Two-dimensional gel electrophoresis-based proteomics and dinitrophenyl hydrazine derivatization technique were used to identify carbonylated proteins. Sequentially, in order to view changes in protein carbonylation pathway, enrichment using Funrich algorithm was performed. The selected carbonylated proteins were validated with western blot and carbonylated sites were further identified by high-resolution LC-MS/MS.ResultsProteomic results and pathway analysis revealed that carbonylated proteins are involved in NASH pathogenesis pathways in which most of them play important roles in energy metabolisms. Particularly, carbonylation level of ATP synthase subunit (ATP5A), a key protein in cellular respiration, was reduced after FA and FA with oxidative stress treatment, whereas its expression was not altered. Carbonylated sites on this protein were identified and it was revealed that these sites are located in nucleotide binding region. Modification of these sites may, therefore, disturb ATP5A activity. As a consequence, the lower carbonylation level on ATP5A after FA treatment solely or with oxidative stress can increase ATP production.ConclusionsThe reduction in carbonylated level of ATP5A might occur to generate more energy in response to pathological conditions, in our case, fat accumulation and oxidative stress in hepatocytes. This would imply the association between protein carbonylation and molecular response to development of steatosis and NASH.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Uncoupling protein-2 and non-alcoholic fatty liver disease
    Baffy, G
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 2082 - 2096
  • [42] Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease
    Nishida, Naoshi
    Yada, Norihisa
    Hagiwara, Satoru
    Sakurai, Toshiharu
    Kitano, Masayuki
    Kudo, Masatoshi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (09) : 1646 - 1653
  • [43] Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
    Spanos, Christos
    Maldonado, Elaina M.
    Fisher, Ciaran P.
    Leenutaphong, Petchpailin
    Oviedo-Orta, Ernesto
    Windridge, David
    Salguero, Francisco J.
    Bermudez-Fajardo, Alexandra
    Weeks, Mark E.
    Evans, Caroline
    Corfe, Bernard M.
    Rabbani, Naila
    Thornalley, Paul J.
    Miller, Michael H.
    Wang, Huan
    Dillon, John F.
    Quaglia, Alberto
    Dhawan, Anil
    Fitzpatrick, Emer
    Moore, J. Bernadette
    [J]. PROTEOME SCIENCE, 2018, 16
  • [44] In Vitro Models for the Study of Non-Alcoholic Fatty Liver Disease
    Chavez-Tapia, N. C.
    Rosso, N.
    Tiribelli, C.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2011, 18 (07) : 1079 - 1084
  • [45] In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications
    Ramos, Maria Jimenez
    Bandiera, Lucia
    Menolascina, Filippo
    Fallowfield, Jonathan Andrew
    [J]. ISCIENCE, 2022, 25 (01)
  • [46] Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism
    Zhou, Yong
    Ding, Yin-Lu
    Zhang, Jian-Liang
    Zhang, Peng
    Wang, Jin-Qing
    Li, Zhao-Hua
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2018, 97 : 1397 - 1408
  • [47] Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases
    Seki, S
    Kitada, T
    Sakaguchi, H
    [J]. HEPATOLOGY RESEARCH, 2005, 33 (02) : 132 - 134
  • [48] Hepatic exposure of metformin in patients with non-alcoholic fatty liver disease
    Sundelin, Elias Immanuel Ordell
    Gormsen, Lars Christian
    Heeboll, Sara
    Vendelbo, Mikkel Holm
    Jakobsen, Steen
    Munk, Ole Lajord
    Feddersen, Soren
    Brosen, Kim
    Hamilton-Dutoit, Stephen Jacques
    Pedersen, Steen Bonlokke
    Gronbaek, Henning
    Jessen, Niels
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (08) : 1761 - 1770
  • [49] Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy
    Tian, Yingxin
    Ni, Yiming
    Zhang, Ting
    Cao, Yemin
    Zhou, Mingmei
    Zhao, Cheng
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [50] Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease
    Monserrat-Mesquida, Margalida
    Quetglas-Llabres, Magdalena
    Abbate, Manuela
    Montemayor, Sofia
    Mascaro, Catalina M.
    Casares, Miguel
    Tejada, Silvia
    Abete, Itziar
    Angeles Zulet, Maria
    Tur, Josep A.
    Alfredo Martinez, J.
    Sureda, Antoni
    [J]. ANTIOXIDANTS, 2020, 9 (08) : 1 - 16